Adult patients in the pediatric emergency department: presentation and disposition

Wendalyn K Little1, Daniel A Hirsh

  • 1From the Departments of *Pediatrics and †Emergency Medicine, Emory University School of Medicine; ‡Pediatric Emergency Medicine, Children's Healthcare of Atlanta; and §Pediatric Emergency Medicine Associates LLC, Atlanta, GA.

Pediatric Emergency Care
|October 25, 2014
PubMed

Insights

Adult patients in pediatric emergency departments (PEDs) are uncommon but present with high acuity, often requiring transfer to adult facilities. Training for PED clinicians is crucial for managing diverse adult illnesses.

Area of Science:

  • Emergency Medicine
  • Pediatric Care
  • Adult Patient Management

Background:

  • Pediatric emergency departments (PEDs) primarily serve children.
  • Adults occasionally seek care in PEDs, posing unique challenges for providers.
  • Understanding adult presentations in PEDs is vital for optimizing care.

Purpose of the Study:

  • To describe the characteristics and presentations of adult patients in two high-volume PEDs.
  • To analyze the demographics, reasons for visit, and diagnoses of adult patients in PEDs.

Main Methods:

  • Retrospective review of electronic medical records for patients aged 21 years and older.
  • Data collected from 2008 to 2010 in a pediatric health care system.
  • Analysis included patient demographics, visit reasons, diagnoses, and treatments.

Main Results:

  • 1097 adult patients visited the PEDs; 188 were under pediatric specialist care.
  • Most adult patients (73%) were female, with a mean age of 36.5 years.
  • 51% were high acuity, 57% required transfer to adult facilities; common complaints included neurologic issues, trauma, and chest pain.

Conclusions:

  • Adult patients in PEDs are rare but present with high acuity.
  • Many adult patients require transfer to adult care facilities.
  • Ongoing training for PED clinicians is necessary to manage adult patients effectively.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
395
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
972
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
532
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
918
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.4K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
391